{"id":481603,"title":"Qualifying notice for Bavencio - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T17:04:53.789000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-bavencio-208742.html?wbdisable=true","snippet":"Qualifying notice for Bavencio Biologics and Genetic Therapies Directorate 100 Eglantine Driveway Address Locator #0601C Ottawa ON K1A 0K9 Dossier ID: HC6-024-e196892 Control #: 208742 Document #: 1309699 [employee name removed] [employee title removed] EMD Serono, A Division of…","rawSnapshotUrl":"/api/snapshots/raw/481603","browseUrl":"https://replay.healtharchive.ca/job-6/20260106170453/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-bavencio-208742.html?wbdisable=true#ha_snapshot=481603","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}